Urogenital Diseases

  • Jawahar L. Tiwari
  • Paul I. Terasaki

Abstract

Shornick et al.1 observed a significantly increased frequency of DR3 in 26 American Caucasian patients (Table 14.1). Similarly, in a small sample of 8 Spanish patients studied by Ferrando et al.2 6 (75%) were positive for DR3. The frequency of this antigen in the control population of unknown size was 14.8%.

Keywords

Psoriasis Infertility Preeclampsia Nephritis Uveitis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Shornick JK, Stastny P, Gilliam JN: High frequency of histocompatibility antigens HLA-DR3 and DR4 in herpes gestationis. J Clin Invest 68:553–555, 1981PubMedGoogle Scholar
  2. 2.
    Ferrando J, Arriaga F, Bordas X, Ercilla G, Vives J, Mascaro JM: Association of HLA-DR3 and Herpes gestationis. Acta Dermatol Venereol (Stockh) 61:462, 1981Google Scholar
  3. 3.
    Reunala T, Karvonen J, Tiilikainen A, Salo OP: Herpes gestationis. Br J Dermatol 96:563–568, 1977PubMedGoogle Scholar
  4. 4.
    Eberst E, Tongio MM, Eberst B, Mayer S, Basset A: Herpes gestationis and anti-HLA immunization. Br J Dermatol 104:553–559, 1981PubMedGoogle Scholar
  5. 1.
    Muravieva LI, Volkova LS, Chen RI: Study of the human leucocyte antigen system in married couples in disturbed reproduction. Akush Ginekol (Mosk) 8:41–43, 1979Google Scholar
  6. 2.
    Gerencer M, Kastelan A, Drazancic A, Kerhin-Brkljacic V, Madharic M: The HLA antigens in women with recurrent abnormal pregnancies of unknown etiology. Tissue Antigens 12:223–227, 1978PubMedGoogle Scholar
  7. 3.
    Gerencer M, Drazancic A, Kuvacic I, Tomaskovie Z, Kastelan A, et al.: HLA antigen studies in women with recurrent gestational disorders. Fértil Steril 31:401–404, 1979PubMedGoogle Scholar
  8. 4.
    Carapella-De Luca E, Purpura M, Coghi I, Nicotra M, Bottini E: Blood groups and histocompatibility antigens in habitual abortion. Haematologia 13:105–111, 1980PubMedGoogle Scholar
  9. 5.
    Purpura M, Coghi I, Nicotra M, Carapella E, Bottini E: HLA Bw35 antigen and human reproduction. J Med Genet 17:157–158, 1980PubMedGoogle Scholar
  10. 6.
    Lauritsen JG, Jorgensen J, Kissmeyer-Nielsen F: Significance of HLA and blood-group incompatibility in spontaneous abortion. Clin Genet 9:575–582, 1976PubMedGoogle Scholar
  11. 7.
    Schacter B, Gyves M, Muir A, Tasin M: HLA-A,B compatibility in parents of offspring with neuraltube defects or couples experiencing involuntary fetal wastage. Lancet i:796–799, 1979Google Scholar
  12. 8.
    Komlos L, Zamir R, Joshua H, Halbrecht I: Common HLA antigens in couples with repeated abortions. Clin Immunol Immunopathol 7:330–335, 1977PubMedGoogle Scholar
  13. 9.
    Beer AE, Quebbeman JF, Ayers JWT, Haines RF: Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. Am J Obstet Gynecol 141:987–999, 1981PubMedGoogle Scholar
  14. 10.
    Tsuji K, Miyamoto H, Motoaki I. HL-A and its clinical application. Keio J Med 21:159–169, 1972PubMedGoogle Scholar
  15. 11.
    Lappe M: HLA homozygosity and neuraltube defects. Lancet i: 1342, 1979Google Scholar
  16. 12.
    Hull P: HLA incompatibility, genetic diversity, and survival. Lancet ii:933–934, 1981Google Scholar
  17. 13.
    Komlos L, Halbrecht I: Repeated abortions and histocompatibility antigens — can HLA antigen restricted gene dose effects influence the feto-maternal relationship? Med Hypotheses 5:901–908, 1979PubMedGoogle Scholar
  18. 14.
    Eberst B, Schumacher JC, Tongio MA, Walch R, Ritter J, Gandar R: Immunisation foeto-maternelle anti-HLA et pathologie gravidique et/ou neo-natale. J Gyn Obstet Biol Reprod (Paris) 7:57–62, 1978Google Scholar
  19. 15.
    Smith RT: The immunobiology of abortion. N Engl J Med 295:1249–1250, 1976PubMedGoogle Scholar
  20. 16.
    Gelabert A, Balasch J, Ercilla G, Vanrell JA, Vives J, Gonzalez-Merlo J, et al.: Abortion may sensitize the mother to HLA antigens. Tissue Antigens 17:353–356, 1981PubMedGoogle Scholar
  21. 17.
    Beer AE, Quebbeman JF, Ayers JWT, Haines RF: Discussion. Am J Obstet Gynecol 143:177–178, 1982Google Scholar
  22. 18.
    Patullo RA: Histocompatibility antigens in pregnancy, abortions, infertility, preeclampsia and trophoblast neoplasms. Am J Reprod Immunol 1:29–34, 1980Google Scholar
  23. 1.
    Scott JR, Beer AE, Stastny P: Immunogenetic factors in preeclampsia and eclampsia: Erythrocyte, histocompatibility, and y-dependent antigens. JAMA 235:402–404, 1976PubMedGoogle Scholar
  24. 2.
    Anichkova SI, Vasilieva ZF, Grigorieva VV: Study of compatibility in married couples according to the HLA antigen system in normal and complicated by late toxemia pregnancy. Akush Ginekol 8:20–23, 1981Google Scholar
  25. 1.
    Scott JR, Beer AE, Stastny P: Immunogenetic factors in preeclampsia and eclampsia: Erythrocyte, histocompatibility, and y-dependent antigens. JAMA 235:402–404, 1976PubMedGoogle Scholar
  26. 2.
    Jenkins DM, Need J, Rajah SM: Deficiency of specific HLA antibodies in severe pregnancy pre-eclampsia/eclampsia. Clin Exp Immunol 27:485–486, 1977PubMedGoogle Scholar
  27. 3.
    Jenkins DM, Need JA, Scott JS, Morris H, Pepper M: Human leucocyte antigens and mixed lymphocyte reaction in severe pre-eclampsia. Br Med J 1:542–544, 1978PubMedGoogle Scholar
  28. 4.
    Redman CWG, Bodmer JG, Bodmer WF, Beilin LJ, Bonnar J: HLA antigens in severe pre-eclampsia. Lancet ii:397–399, 1978Google Scholar
  29. 5.
    Simon P, Fauchet R, Menault M, Bombail D, Lefiblec B, Panguy E, et al.: HLA A, B, and DR antigens in pre-eclampsia: Preliminary results. Kidney Int 17:705–706, 1980Google Scholar
  30. 6.
    Pattillo RA: Histocompatibility antigens in pregnancy, abortions, infertility, preeclampsia and trophoblast neoplasms. Am J Reprod Immunol 1:29–34, 1980PubMedGoogle Scholar
  31. 7.
    Anichkova SI, Vasilieva ZF, Grigorieva VV: Study of compatibility in married couples according to the HLA antigen system in normal and complicated by late toxemia pregnancy. Akush Ginekol 8:20–23, 1981Google Scholar
  32. 1.
    Kamidono S, Matsumoto O, Ishigami J, Nakao Y, Tsuji K: Infertility and HLA antigen: Male infertility and infertile couples. Andrologia 12:317–322, 1980PubMedGoogle Scholar
  33. 2.
    Lindblom JB, Friberg J, Hogman CF, Gemzell C: HL-A haplotypes and unexplained infertility. Tissue Antigens 2:352–358, 1972PubMedGoogle Scholar
  34. 3.
    Malzer VG, Freistedt B, Berge H, Felker A, Hentschel W: Bereichert das HLA-System unsere Moglichkeiten im Rahmen der sterilitats-Diagnostik? Zentralbl Gynakol 101:72–74, 1979PubMedGoogle Scholar
  35. 4.
    Purpura M, Coghi I, Nicotra M, Carapella E, Bottini E: HLA Bw35 antigen and human reproduction. J Med Genet 17:157–158, 1980PubMedGoogle Scholar
  36. 5.
    Pattillo RA: Histocompatibility antigens in pregnancy, abortions, infertility, preeclampsia and trophoblast neoplasms. Am J Reprod Immunol 1:29–34, 1980PubMedGoogle Scholar
  37. 1.
    Willscher MK, Cwazka WF, Novicki DE: The association of histocompatibility antigens of the B7 cross-reacting group with Peyronie’s disease. J Urol 122:34–35, 1979PubMedGoogle Scholar
  38. 2.
    Leffell MS, Devine CJ, Horton CE, Somers KD, Dawson D, Vande Berg JS, et al: Non-association of Peyronie’s disease with HLA B7 cross-reactive antigens. J Urol 127:1223–1224,1982PubMedGoogle Scholar
  39. 3.
    Nyberg LM, Bias WB, Hochberg MC, Walsh P: Identification of an inherited form of Peyronie’s disease with autosomal dominant inheritance and association with Dupuytren’s contracture and HLA-B7 cross-reacting antigens. J Urol 128:48–51, 1982PubMedGoogle Scholar
  40. 1.
    Lassus A, Tiilikainen A, Stubb S, Reunala T, Johansson E: Circinate erosive balanitis and HL-A 27. Acta Dermatov 55:199–201, 1975Google Scholar
  41. 1.
    Sengar DPS, Rashid A, Wolfish NM: Familial urinary tract anomalies: Association with the major histocompatibility complex in man. J Urol 121:194–197, 1979PubMedGoogle Scholar
  42. 2.
    Sengar DPS, Rashid A, Wolfish NM: Histocompatibility antigens and urinary abnormalities. Br Med J 1:1146, 1978PubMedGoogle Scholar
  43. 1.
    Kamidono S, Matsumoto O, Ishigami J, Nakao Y, Tsuji K: Infertility and HLA antigen: Male infertility and infertile couples. Andrologia 12:317–322, 1980PubMedGoogle Scholar
  44. 2.
    Mueller-Eckhardt G, Krause W, Schierke G, Mueller-Eckhardt C: Male infertility due to idiopathic disorders of spermatogenesis: No association with HLA. Tissue Antigens 20:270–273, 1982PubMedGoogle Scholar
  45. 1.
    Bailey RR, Wallace M: HLA-B12 as a genetic marker for vesicoureteric reflux. Br Med J 1:48–49, 1978PubMedGoogle Scholar
  46. 2.
    Torres VE, Moore SB, Kurtz SB, Offord KP, Kelalis PP: In search of a marker for genetic susceptibility to reflux nephropathy. Clin Nephrol 14:217–222, 1980PubMedGoogle Scholar
  47. 3.
    Sengar DPS, Rashid A, Wolfish NM: Histocompatibility antigens and urinary abnormalities. Br Med J 1:1146, 1978PubMedGoogle Scholar
  48. 4.
    Sengar DPS, Rashid A, Wolfish NM: Familial urinary tract anomalies: Association with the major histocompatibility complex in man. J Urol 121:194–197, 1979PubMedGoogle Scholar
  49. 1.
    Fauchet R, Gueguen M, Genetet B, Pogamp PL, Ramee MP, Chevet D, et al: HLA-DR antigen and IgA nephropathy (Berger’s disease). N Engl J Med 302:1033–1034, 1980PubMedGoogle Scholar
  50. 2.
    Bignon JD, Houssin A, Soulillou JP, Denis J, Guimbretiere J, Guenel J: HLA antigens and Berger’s disease. Tissue Antigens 16:108–111, 1980PubMedGoogle Scholar
  51. 3.
    Le Petit JC, Cases MH, Berthoux FC, Van Loghem E, Goguen J, Seger J, et al: Genetic investigation in mesangial IgA nephropathy. Tissue Antigens 19:108–114, 1982PubMedGoogle Scholar
  52. 4.
    Brettle R, Peters DK, Batchelor JR: Mesangial IgA glomerulonephritis and HLA antigens. N Engl J Med 299:200, 1978PubMedGoogle Scholar
  53. 5.
    Komori K, Nose Y, Inouye H, Tsuji K, Nomoto Y, Sakai H: Study on HLA system in IgA nephropathy. Tissue Antigens 14:32–36, 1979PubMedGoogle Scholar
  54. 6.
    Chan Sh, Ku G, Sinniah R: HLA and Chinese IgA mesangial glomerulonephritis. Tissue Antigens 17:351–352, 1981PubMedGoogle Scholar
  55. 7.
    Sabatier JC, Genin C, Assenat H, Colon S, Ducret F, Berthoux FC: Mesangial IgA glomerulonephritis in HLA-identical brothers. Clin Nephrol 11:35–38, 1979PubMedGoogle Scholar
  56. 8.
    Katz A, Karanicolas S, Falk JA: Family study in IgA nephritis: The possible role of HLA antigens. Transplantation 29:505–506, 1980PubMedGoogle Scholar
  57. 9.
    Houssin A, Bignon JD, Soulillou JP, Guimbretiere J, Guenel J: HLA phenotypes in Berger’s disease. Kidney Int 17:702–703, 1980Google Scholar
  58. 10.
    Pogamp PL, Fauchet R, Ramee MP: HLA-DRW4 antigen and IgA-nephropathy (Berger’s disease). Eur J Clin Invest 10:29, 1980Google Scholar
  59. 11.
    Richman AV, Mahoney JJ, Fuller TJ: Higher prevalence of HLA-B12 in patients with IgA nephropathy. Ann Intern Med 90:201, 1979PubMedGoogle Scholar
  60. 12.
    Nagy J, Hamori A, Ambrus M, Hernadi E: More on IgA glomerulonephritis and HLA antigens. N Engl J Med 300:92, 1979PubMedGoogle Scholar
  61. 13.
    Noel LH, Descamps B, Jungers P, Bach JF, Bussom M, Suet C, et al: HLA antigens in three types of glomerulonephritis. Clin Immunol Immunopathol 10:19–23, 1978PubMedGoogle Scholar
  62. 14.
    Savi M, Neri TM, Silvestri MG, Allegri L, Migone L: HLA antigens and IgA mesangial glomerulonephritis. Clin Nephrol 12:45–46, 1979PubMedGoogle Scholar
  63. 15.
    Arnaiz-Villena A, Gonzalo A, Mampaso F, Teruel JL, Ortunno J: HLA and IgA nephropathy in Spanish population. Tissue Antigens 17:549–550, 1981PubMedGoogle Scholar
  64. 16.
    O’Neill S, Walker F, Spencer S, O’Dwyer WF: HLA status in IgA nephropathy. Irish J Med Sci 150:113–115, 1981PubMedGoogle Scholar
  65. 17.
    Mustonen J, Pasternack A, Helin H, Rilva A, Penttinen K, Wager O, et al: Circulating immune complexes, the concentration of serum Ig A and the distribution of HLA antigens in Ig A nephropathy. Nephron 29:170–175, 1981PubMedGoogle Scholar
  66. 18.
    Berthoux FC, Gagne A, Sabatier JC, Ducret F, Le Petit SC, Marceliin M, et al: HLA-BW35 and mesangial Ig A glomerulonephritis. N Engl J Med 298:1034–1035, 1978PubMedGoogle Scholar
  67. 19.
    Hiki Y, Kobayashi Y, Tateno S, Sada M, Kashiwagi N: Strong association of HLA-DR4 with benign IgA nephropathy. Nephron 32:222–226, 1982PubMedGoogle Scholar
  68. 20.
    Kashiwabara H, Shishido H, Tomura S, Tuchida H, Miyajima T: Strong association between IgA nephropathy and HLA-DR4 antigen. Kidney Int 22:377–382, 1982PubMedGoogle Scholar
  69. 21.
    Kashwabara H, Shishido H, Yokoyama T, Miyajima T: HLA in IgA nephropathy. Tissue Antigens 16:411–412, 1980PubMedGoogle Scholar
  70. 22.
    Fauchet R, Le Pogamp P, Genetet B, Chevet D, Gueguen M, Simon P, et al: HLA-DR4 antigen and IgA nephropathy. Tissue Antigens 16:405–410, 1980PubMedGoogle Scholar
  71. 23.
    Kasahara M, Hamada K, Okuyama T, Ishikawa N, Ogasawara K, Dceda H, et al: Role of HLA in IgA nephropathy. Clin Immunol Immunopathol 25:189–195, 1982PubMedGoogle Scholar
  72. 1.
    Patel R, Mickey MR, Terasaki PI: Leukocyte antigens and disease: I. Association of HL-A2 and chronic glomerulonephritis. Br Med J 2:424–426, 1969PubMedGoogle Scholar
  73. 2.
    Mickey MR, Kreisler M, Terasaki PI: Leukocyte antigens and disease. II. Alterations in frequencies of haplotypes associated with chronic glomerulonephritis. In Terasaki PI (ed): Histocompatibility Testing 1970. Munksgaard, Copenhagen, 1970, pp 237–242Google Scholar
  74. 3.
    Jensen H, Ryder LP, Staub Nielsen L, Clausen E, Jorgensen F, Elif Jorgensen H: HLA antigens and glomerulonephritis. Tissue Antigens 6:368–369, 1975Google Scholar
  75. 4.
    Nyulassy S, Buc M, Sasinka M, Pavlovic M, Slugen I, Hirschova V, et al.: The HLA system in glomerulonephritis. Clin Immunol Immunopathol 7:319–323, 1977PubMedGoogle Scholar
  76. 5.
    De Mouzon-Cambon A, Ohayon E, Bouissou F, Barthe P: HLA-DR typing in children with glomerular diseases. Lancet ii:868, 1980Google Scholar
  77. 6.
    Stefanova S, Andreev IG: HLA system and renal diseases. Ind J Exp Biol 18:282–284, 1980Google Scholar
  78. 1.
    Read SE, Reid H, Poon-King T, Fischetti VA, Zabriskie JB, Rapaport FT: HLA and predisposition to the nonsuppurative sequelae of group A streptococcal infections. Transplant Proc 9:543–546, 1977PubMedGoogle Scholar
  79. 2.
    Sasazuki T, Hayase R, Iwamoto I, Tsuchida H: HLA and acute poststreptococcal glomerulonephritis. N Engl J Med 301:1184–1185, 1979PubMedGoogle Scholar
  80. 3.
    Sasazuki T, Kaneoka H, Ohta N, Hayase R, Iwamoto I: Common HLA haplotypes and their association with diseases in the Japanese population. Transplant Proc 11:1871–1873, 1979PubMedGoogle Scholar
  81. 4.
    Layrisse Z, Rodriguez-Iturbe B, Garcia-Ramirez R, Rodriguez A, Tiwari J: Family studies of the HLA system in acute post-streptococcal glomerulonephritis. Hum Immunol 7:177–185, 1983PubMedGoogle Scholar
  82. 5.
    Rodriguez-Iturbe B, Moreno-Fuenmayor H, Rubio L, Garcia R, Layrisse Z: Mendelian recessive ratios in acute poststreptococcal glomerulonephritis. Exper-ientia (in press)Google Scholar
  83. 1.
    Klouda PT, Acheson EJ, Goldby FS, Lawler W, Manos J, Dyer PA, et al.: Strong association between idiopathic membranous nephropathy and HLA-DRW3. Lancet ii:770–771, 1979Google Scholar
  84. 2.
    Dyer PA, Klouda PT, Harris R, Mallick NP: Properdin factor B alleles in patients with idiopathic membranous nephropathy. Tissue Antigens 15:505–507, 1980PubMedGoogle Scholar
  85. 3.
    Davies MG, Davies PG: Dermatitis herpetiformis, glomerulonephritis, and HLA-DRW3. Lancet ii:911, 1979Google Scholar
  86. 4.
    Le Petit JC, Laurent B, Berthoux FC: HLA-DR3 and idiopathic membranous nephritis (IMN) association. Tissue Antigens 20:227–228, 1982PubMedGoogle Scholar
  87. 5.
    Garavoy MR: Idiopathic membranous glomerulonephritis: An HLA-associated disease. In Terasaki PI (ed): Histocompatibility Testing 1980. UCLA Tissue Typing Laboratory, Los Angeles, 1981, pp 673–680Google Scholar
  88. 6.
    Muller GA, Muller C, Liebau G, Kompf J, Ising H, Wernet P: Strong association of idiopathic membranous nephropathy (IMN) with HLA-DR3 and MT-2 without involvement of HLA-B18 and no association to BfFl. Tissue Antigens 17:332–337, 1981PubMedGoogle Scholar
  89. 1.
    Minev M, Mikhaylov T, Kastelan A, Nyulassy S, Menzel G: HLA system and Balkan endemic nephropathy. Tissue Antigens 11:50–54, 1978PubMedGoogle Scholar
  90. 2.
    Stefanova S, Andreev IG: HLA system and renal diseases. Indian J Exp Biol 18:282–284, 1980PubMedGoogle Scholar
  91. 1.
    Nyulassy S, Buc M, Sasinka M, Pavlovic M, Slugen I, Hirschova V, et al: The HLA system in glomerulonephritis. Clin Immunol Immunopathol 7:319–323, 1977PubMedGoogle Scholar
  92. 2.
    De Mouzon-Cambon A, Bouissou F, Dutau G, Barthe Ph, Parra MT, Sevin A, et al: HLA-DR7 in children with idiopathic nephrotic syndrome. Correlation with atopy. Tissue Antigens 17:518–524, 1981PubMedGoogle Scholar
  93. 3.
    Noss G, Bachmann HJ, Olbing H: Association of minimal change nephrotic syndrome (MCNS) with HLA-B8 and B13. Clin Nephrol 15:172–174, 1981PubMedGoogle Scholar
  94. 4.
    Dippell J, Wonne R: Atopie, HLA-System und steroidsensibles nephrotisches Syndrom im Kindesalter. Monatschr Kinderheilkd 129:684–687, 1981Google Scholar
  95. 5.
    De Mouzon-Cambon A, Ohayon E, Bouissou F, Barthe P: HLA-DR typing in children with glomerular diseases. Lancet ii:868, 1980Google Scholar
  96. 6.
    Nunez-Roldan A, Vellechenous E, Fernandez-An-drade C, Martin-Govantes J: Increased HLA-DR7 and decreased DR2 in steroid-responsive nephrotic syndrome. N Engl J Med 306:366–367, 1982PubMedGoogle Scholar
  97. 1.
    Thomson PD, Barret TM, Stokes CR, Turner MW, Soothill JF: HLA antigens and atopic features in steroid-responsive nephrotic syndrome of childhood. Lancet ii:765–768, 1976Google Scholar
  98. 2.
    Thomson PD, Barrat TM, Stokes CR, Soothill JF, Turner MW: HLA typing and atopic features in steroid sensitive nephrotic syndrome of childhood. Monogr Allergy 11:60, 1977PubMedGoogle Scholar
  99. 3.
    O’Regan D, O’Callaghan U, Dundon S, Reen DJ: HLA antigens and steroid responsive nephrotic syndrome of childhood. Tissue Antigens 16:147–151, 1980PubMedGoogle Scholar
  100. 4.
    Alfiler CA, Roy LP, Doran T, Sheldon A, Bashir H: HLA-DRW7 and steroid-responsive nephrotic syndrome of childhood. Clin Nephrol 14:71–74, 1980PubMedGoogle Scholar
  101. 1.
    Descamps B, Jüngers P, Naret C, Degott C, Zingraff J, Bach JF: HLA-A1, B8-phenotype association and HB S antigenemia evolution in 440 hemodialyzed patients. Digestion 15:271–277, 1977PubMedGoogle Scholar
  102. 2.
    Bach JF, Zingraff J, Descamps B, Naret C, Jüngers P: HL-A1, 8 phenotype and HB S antigenaemia in haemodialysis patients. Lancet ii:707, 1975Google Scholar
  103. 3.
    Jüngers MP, Descamps B, Zingraff J, Naret C, Bach JF: Sur une correlation entre les antigenes d’histo-compatibilite HL-Al et 8 et une meilleure defense de l’uremique chronique contre le virus de l’hépatite B. C R Acad Sci (Paris) 281:675–678, 1975Google Scholar
  104. 4.
    Patterson MJ, Hourani MR, Mayor GH: HLA antigens and hepatitis B virus. N Engl J Med 297:1124, 1977PubMedGoogle Scholar
  105. 5.
    Hillis WD, Hillis A, Bias WB, Walker WG: Associations of hepatitis B surface antigenemia with HLA locus B specificities. N Engl J Med 296:1310–1314, 1977PubMedGoogle Scholar
  106. 6.
    Sengar DPS, Rashid A, Jindal SL, Christie CJ: HLA antigens in HBSAG infection. Vox Sang 36:353–355, 1979PubMedGoogle Scholar
  107. 7.
    Sengar DPS, McLeish WA, Sutherland M, Couture RA, Rashid A: Hepatitis B antigen (HBAG) infection in a hemodialysis unit. I. HL-A8 and immune response to HBAG. Can Med Assoc J 112:968–971, 1975PubMedGoogle Scholar
  108. 1.
    Descamps B, Jüngers P, Naret C, Degott C, Zingraff, Bach JF: HLA-A1, B8-phenotype association and HBS antigenemia evolution in 440 hemodialyzed patients. Digestion 15:271–277, 1977PubMedGoogle Scholar
  109. 2.
    Bach JF, Zingraff J, Descamps B, Naret C, Jüngers P: HL-A1, 8 phenotype and HBS antigenaemia in haemodialysis patients. Lancet ii:707, 1975Google Scholar
  110. 3.
    Jüngers MP, Descamps B, Zingraff J, Naret C, Bach JF: Sur une correlation entre les antigenes d’histo-compatibilite HL-Al et 8 et une meilleure defense de l’uremique chronique contre le virus de l’hépatite B. C R Acad Sci (Paris) 281:675–678, 1975Google Scholar
  111. 4.
    Patterson MJ, Hourani MR, Mayor GH: HLA antigens and hepatitis B virus. N Engl J Med 297:1124, 1977PubMedGoogle Scholar
  112. 5.
    Hillis WD, Hillis A, Bias WB, Walker WG: Associations of hepatitis B surface antigenemia with HLA locus B specificities. N Engl J Med 296:1310–1314, 1977PubMedGoogle Scholar
  113. 6.
    Adorno D, Valeri M, Piazzi A, Bonini S, Papóla F, Casciani CU: Lymphocytotoxic HLA antibodies and HB infection in transfused hemodialysis patients waiting for kidney transplantation. Transplant Proc 11:1269–1270, 1979PubMedGoogle Scholar
  114. 1.
    Descamps B, Jungers P, Naret C, Degott C, Zingraff J, Bach JF: HLA-A1, B8-phenotype association and HBS antigenemia evolution in 440 hemodialyzed patients. Digestion 15:271–277, 1977PubMedGoogle Scholar
  115. 2.
    Bach JF, Zingraff J, Descamps B, Naret C, Jüngers P: HL-A1, 8 phenotype and HBS antigenaemia in haemodialysis patients. Lancet ii:707, 1975Google Scholar
  116. 3.
    Jüngers MP, Descamps B, Zingraff J, Naret C, Bach JF: Sur une correlation entre les antigenes d’histo-compatibilite HL-Al et 8 et une meilleure defense de l’uremique chronique contre le virus de l’hepatite B. C R Acad Sci (Paris) 281:675–678, 1975Google Scholar
  117. 4.
    Patterson MJ, Hourani MR, Mayor GH: HLA antigens and hepatitis B virus. N Engl J Med 297:1124, 1977PubMedGoogle Scholar
  118. 5.
    Hillis WD, Hillis A, Bias WB, Walker WG: Associations of hepatitis B surface antigenemia with HLA locus B specificities. N Engl J Med 296:1310–1314, 1977PubMedGoogle Scholar
  119. 6.
    Sengar DPS, Rashid A, Jindal SL, Christie CJ: HLA antigens in HBsAg infection. Vox Sang 36:353–355, 1979PubMedGoogle Scholar
  120. 7.
    Sengar DPS, McLeish WA, Sutherland M, Couture RA, Rashid A: Hepatitis B antigen (HBAG) infection in a hemodialysis unit. I. HL-A8 and immune response to HBAG. Can Med Assoc J 112:968–971, 1975PubMedGoogle Scholar
  121. 8.
    Adorno D, Valeri M, Piazzi A, Bonini S, Papóla F, Casciani CU: Lymphocytotoxic HLA antibodies and HB infection in transfused hemodialysis patients waiting for kidney transplantation. Transplant Proc 11:1269–1270, 1979PubMedGoogle Scholar
  122. 1.
    Opelz G, Terasaki PI: Graft survival rates and HLA antigen frequencies in renal cadaver transplant recipients with hepatitis B antigenemia. Transplantation 25:159–160, 1978PubMedGoogle Scholar
  123. 1.
    Macurova H, Prat V, Ivaskova E: HLA antigens in polycystic kidneys. Cas Lek Cesk 118:1296–1298, 1979PubMedGoogle Scholar
  124. 2.
    Dyer PA, Watters EA, Klouda PT, Harris R, Mallick NP: Absence of linkage between adult polycystic kidney disease and the major histocompatibility system. Tissue Antigens 20:108–111, 1982PubMedGoogle Scholar
  125. 1.
    Willscher MK, Novicki DE, Cwazka WF: Association of HLA-B27 antigen with retroperitoneal fibrosis. J Urol 120:631–633, 1978PubMedGoogle Scholar
  126. 2.
    Norton JH: Idiopathic retroperitoneal fibrosis. J Urol 121:689–690, 1979PubMedGoogle Scholar
  127. 3.
    Vital Durand D, Rouhier D, Brette R: Could the HLA-B27 antigen be a predisposing factor in the development of fibrotic changes? J Urol 124:162, 1980Google Scholar
  128. 4.
    Fernandez-Herlihy L: Idiopathic retroperitoneal fibrosis and HLA-B27. J Urol 124:752, 1980PubMedGoogle Scholar
  129. 1.
    Chen WY, Hsieh BS, Yen TS, Hsia S: Histocompatibility antigen of patients with renal insufficiency tested by immune adherence. J Formosn Med Assoc 73:359–364, 1974Google Scholar
  130. 2.
    Fehrman I, Ringden O: Lymphocytes from multi-transfused uremic patients have poor MLC reactivity. Tissue Antigens 17:386–395, 1981PubMedGoogle Scholar
  131. 1.
    Migliorini P, Bombardieri S, Castellani A, Ferrara GB: HLA antigens in essential mixed cryoglobulinemia (EMC). Eur J Clin Invest 10:26, 1980Google Scholar
  132. 1.
    Sengar DPS, Rashid A, Couture RA, Schieman L, Acharya C, Wolfish NM: HLA and familial benign hematuria. Transplantation 31:310–311, 1981PubMedGoogle Scholar
  133. 1.
    Moller P, Vinje O, Fryjordet A: HLA antigens and sacro-iliitis in chronic prostatitis. Scand J Rheumatol 9:138–140, 1980PubMedGoogle Scholar
  134. 2.
    Moller P, Berg K, Vinje O: HLA phenotypes and joint affection in psoriasis, acute anterior uveitis and chronic prostatitis. Clin Genet 19:266–270, 1981PubMedGoogle Scholar
  135. 1.
    Djawari VD, Deinlein E: Zur Immunologie des Bak-terid Andrews II: HLA-Typisierung. Dermatol Monatsschr 166:305–308, 1980PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1985

Authors and Affiliations

  • Jawahar L. Tiwari
    • 1
  • Paul I. Terasaki
    • 2
  1. 1.Center for The Health SciencesUCLA Tissue Typing LaboratoryLos AngelesUSA
  2. 2.UCLA Hospital and ClinicsLos AngelesUSA

Personalised recommendations